Discover how much money can be saved in your clinical trial!

RESEARCH SITES AND SPONSORS COOPERATE TO PREVENT PROFESSIONAL RESEARCH SUBJECTS IN CNS CLINICAL TRIALS BY USING VERIFIED CLINICAL TRIALS

Duplicate subjects, or what is known as professional research subjects, exist in most clinical trials to varying degrees. CNS clinical trials are especially prone to duplicate subjects or over enrollment in clinical tials. The issue exists from phase 1 healthy volunteer studies to multiple phase 2/3 clinical trials across many therapeutic indications. Use of global …

Read more

Screen Shot 2019 05 30 at 12.33.36 PM

Understanding Research Subjects Behaviors & Travel Habits: Duplicate Subjects In CNS Clinical Trials

Verified Clinical Trials (VCT) presented a poster at the ASCP meeting in Phoenix May 2019, detailing travel habits and distances specifically in CNS clinical trials. Bottom line: In many instances, research subjects travel large distances to become duplicate subjects in CNS clinical trials. A research subject database is needed to prevent duplicate subjects and many …

Read more

Screen Shot 2021 08 06 at 2.24.20 PM

Verified Clinical Trials Partners With The STARR Coalition To Promote Advocacy And Reduce Duplicate Subjects In CNS Clinical Trials

Verified Clinical Trials (VCT) the leading global research subject database registry has teamed up with the STARR Coalition to create Project RockSTARR. The initiative allows sponsors to have research subjects that screen for a clinical trial donate a pre-allocated amount of money to local advocacy group of their choice. Advocacy and duplicate subject prevention in …

Read more

Screen Shot 2019 04 30 at 4.03.56 PM

Verified Clinical Trials (VCT) will be exhibiting again at the EUFEMED meeting in France May 15-17. VCT is the global research subject database registry utilized by phase 1- phase 4 clinical trials across the globe. VCT prevents over enrollment or duplicate subjects as well as many other key protocol violations to promote safety and data …

Read more

The Verified Clinical Trials Research Subject Registry Reduces Duplicate Subjects And Professional Research Subjects In CNS Clinical Trials

The Verified Clinical Trials Research Subject Registry Reduces Duplicate Subjects And Professional Research Subjects In CNS Clinical Trials. Verified Clinical Trials is a global research subject database registry. The registry is used by thousands of research sites across the US and in Europe to prevent many protocol deviations and most importantly, duplicate subjects in clinical …

Read more

Characteristics Of Professional Research Subjects and Duplicate Subjects In CNS and Other Clinical Trials Prevented By Verified Clinical Trials

Professional research subjects or duplicate subjects in clinical trials cause safety concerns and poor quality data.  The Verified Clinical Trials global research subject database registry is a tool to detect duplicate subjects and prevents many protocol violations proactively at the time of screening.  What we have learned from experience and analytical data review over the …

Read more

Verified Clinical Trials Announced as a Finalist in Best Sponsor-Focused Technological Development in 2019 Clinical & Research Excellence Awards

Garden City, NY. March 5th2019–Verified Clinical Trials has been named a finalist in “Best Sponsor-Focused Technological Development”  in the CARE Awards, which recognize outstanding work across the global clinical research enterprise. The 2019 winners will be announced at a ceremony on Thursday, 2 May at the Hyatt Regency Boston, MA, where we gather distinguished leaders …

Read more

Screen Shot 2019 02 07 at 1.32.54 PM

Professional Research Subjects: Not Just a Regional Problem

Preventable protocol violations and professional research subjects exist across the globe. It is NOT just a regional problem. If you look at the protocol violations by verification with the Verified Clinical Trials (VCT) system one can see that the issue is significant throughout the country. Duplicate subjects can cause a trial to fail.  Issues with increased …

Read more